Evaluation of the Safety, Efficacy, Pharmacokinetics, and Acceptability of HMR3647 20 mg/kg qd for 5 Days With Acute Otitis Media (AOM) in Children (Multicentre, Open Label, Non Comparative Study)

Trial Profile

Evaluation of the Safety, Efficacy, Pharmacokinetics, and Acceptability of HMR3647 20 mg/kg qd for 5 Days With Acute Otitis Media (AOM) in Children (Multicentre, Open Label, Non Comparative Study)

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2008

At a glance

  • Drugs Telithromycin (Primary)
  • Indications Bacterial infections; Otitis media
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 03 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top